Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Non-activated, amorphous, pH neutral, two-part bedside-ready clay delivery system that treats pathogen infections in humans and animals

Non-activated, amorphous, pH neutral, two-part bedside-ready clay delivery system that treats pathogen infections in humans and animals

US Patent 11638759 · Granted May 2, 2023

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Non-activated, amorphous, pH neutral, two-part bedside-ready clay delivery syste2025
Coated medicinal clay compositions, pharmaceutical compositions, and delivery of2025
Hydroxytyrosol and oleuropein compositions for induction of DNA damage, cell dea2019
Hydroxytyrosol and oleuropein compositions for induction of DNA damage, cell dea2017
Compositions for anti-inflammatory, antioxidant effects and improved respiratory2017
Nutritional supplements2016
Hydroxytyrosol and oleuropein compositions for induction of DNA damage, cell dea2015
Methods for improved wound closure employing olivamine and endothelial cells2015
Nutritional supplements2014
Methods for improved wound closure employing olivamine and human umbilical vein 2014
Compositions and methods for wound care2014